WHO and UNICEF. Health in the post-2015 development agenda report of the Global Thematic Consultation on Health. World We Want. 31:514–526. 2014.

Dora C, Haines A, Balbus J, Fletcher E, Adair-Rohani H, Alabaster G, Hossain R, de Onis M, Branca F and Neira M: Indicators linking health and sustainability in the post-2015 development agenda. Lancet. 385:380–391. 2015.PubMed/NCBI View Article : Google Scholar

Novelli G, Biancolella M, Latini A, Spallone A, Borgiani P and Papaluca M: Precision medicine in non-communicable diseases. High-Throughput. 9(3)2020.PubMed/NCBI View Article : Google Scholar

Imaoka T, Nishimura M, Daino K, Takabatake M, Moriyama H, Nishimura Y, Morioka T, Shimada Y and Kakinuma S: Risk of second cancer after ion beam radiotherapy: Insights from animal carcinogenesis studies. Int J Radiat Biol. 95:1431–1440. 2019.PubMed/NCBI View Article : Google Scholar

O'Malley RB and Revels JW: Imaging of abdominal postoperative complications. Radiol Clin North Am. 58:73–91. 2020.PubMed/NCBI View Article : Google Scholar

Suri S, Kumar V, Kumar S, Goyal A, Tanwar B and Kaur J and Kaur J: DASH dietary pattern: A treatment for non-communicable diseases. Curr Hypertens Rev. 16:108–114. 2020.PubMed/NCBI View Article : Google Scholar

Zhu J, Yang J and Luo Y: Applications of engineered intestinal bacteria in disease diagnosis and treatment. Sheng Wu Gong Cheng Xue Bao. 35:2350–2366. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).

Parséus A, Sommer N, Sommer F, Caesar R, Molinaro A, Ståhlman M, Greiner TU, Perkins R and Bäckhed F: Microbiota-induced obesity requires farnesoid X receptor. Gut. 66:429–437. 2017.PubMed/NCBI View Article : Google Scholar

Kostic AD, Gevers D, Siljander H, Vatanen T, Hyötyläinen T, Hämäläinen AM, Peet A, Tillmann V, Pöhö P, Mattila I, et al: The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe. 17:260–273. 2015.PubMed/NCBI View Article : Google Scholar

Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, et al: A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 490:55–60. 2012.PubMed/NCBI View Article : Google Scholar

Zhang M, Sun K, Wu Y, Yang Y, Tso P and Wu Z: Interactions between intestinal microbiota and host immune response in inflammatory bowel disease. Front Immunol. 8(942)2017.PubMed/NCBI View Article : Google Scholar

Lu T, Chen Y, Guo Y, Sun J, Shen W, Yuan M, Zhang S, He P and Jiao X: Altered gut microbiota diversity and composition in chronic urticaria. Dis Markers. 2019(6417471)2019.PubMed/NCBI View Article : Google Scholar

Cryan JF, O'Riordan KJ, Sandhu K, Peterson V and Dinan TG: The gut microbiome in neurological disorders. Lancet Neurol. 19:179–194. 2020.PubMed/NCBI View Article : Google Scholar

Jiménez-Avalos JA, Arrevillaga-Boni G, González-López L, García-Carvajal ZY and González-Avila M: Classical methods and perspectives for manipulating the human gut microbial ecosystem. Crit Rev Food Sci Nutr: Mar 2, 2020 (Epub ahead of print). doi: 10.1080/10408398.2020.1724075.

Szajewska H: What are the indications for using probiotics in children? Arch Dis Child. 101:398–403. 2016.PubMed/NCBI View Article : Google Scholar

Chua KJ, Kwok WC, Aggarwal N, Sun T and Chang MW: Designer probiotics for the prevention and treatment of human diseases. Curr Opin Chem Biol. 40:8–16. 2017.PubMed/NCBI View Article : Google Scholar

Sanders ME, Akkermans LMA, Haller D, Hammerman C, Heimbach J, Hörmannsperger G, Huys G, Levy DD, Lutgendorff F, Mack D, et al: Safety assessment of probiotics for human use. Gut Microbes. 1:164–185. 2010.PubMed/NCBI View Article : Google Scholar

Khangwal I and Shukla P: Combinatory biotechnological intervention for gut microbiota. Appl Microbiol Biotechnol. 103:3615–3625. 2019.PubMed/NCBI View Article : Google Scholar

Yadav M and Shukla P: Recent systems biology approaches for probiotics use in health aspects: A review. 3 Biotech. 9(448)2019.PubMed/NCBI View Article : Google Scholar

Kumar M, Yadav AK, Verma V, Singh B, Mal G, Nagpal R and Hemalatha R: Bioengineered probiotics as a new hope for health and diseases: An overview of potential and prospects. Future Microbiol. 11:585–600. 2016.PubMed/NCBI View Article : Google Scholar

Yadav R, Singh PK and Shukla P: Metabolic engineering for probiotics and their genome-wide expression profiling. Curr Protein Pept Sci. 19:68–74. 2018.PubMed/NCBI View Article : Google Scholar

Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W and Remaut E: Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. 289:1352–1355. 2000.PubMed/NCBI View Article : Google Scholar

Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP and Steidler L: A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol. 4:754–759. 2006.PubMed/NCBI View Article : Google Scholar

Kurtz CB, Millet YA, Puurunen MK, Perreault M, Charbonneau MR, Isabella VM, Kotula JW, Antipov E, Dagon Y, Denney WS, et al: An engineered E. Coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci Transl Med. 11(eaau7975)2019.PubMed/NCBI View Article : Google Scholar

Saltzman DA, Katsanis E, Heise CP, Hasz DE, Vigdorovich V, Kelly SM, Curtiss R III, Leonard AS and Anderson PM: Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: A novel antitumor agent? J Pediatr Surg. 32:301–306. 1997.PubMed/NCBI View Article : Google Scholar

Fang X, Tian P, Zhao X, Jiang C and Chen T: Neuroprotective effects of an engineered commensal bacterium in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinson disease mouse model via producing glucagon-like peptide-1. J Neurochem. 160:441–452. 2019.PubMed/NCBI View Article : Google Scholar

Yang G, Jiang Y, Yang W, Du F, Yao Y, Shi C and Wang C: Effective treatment of hypertension by recombinant Lactobacillus plantarum expressing angiotensin converting enzyme inhibitory peptide. Microb Cell Fact. 14(202)2015.

Cani PD and de Vos WM: Next-generation beneficial microbes: The case of Akkermansia muciniphila. Front Microbiol. 8(1765)2017.PubMed/NCBI View Article : Google Scholar

Rodríguez V, Asenjo JA and Andrews BA: Design and implementation of a high yield production system for recombinant expression of peptides. Microb Cell Fact. 13(65)2014.PubMed/NCBI View Article : Google Scholar

Sahdev S, Khattar SK and Saini KS: Production of active eukaryotic proteins through bacterial expression systems: A review of the existing biotechnology strategies. Mol Cell Biochem. 307:249–264. 2008.PubMed/NCBI View Article : Google Scholar

Chance RE and Frank BH: Research, development, production, and safety of biosynthetic human insulin. Diabetes Care. 16 (Suppl 3):S133–S142. 1993.PubMed/NCBI View Article : Google Scholar

Whelan RA, Rausch S, Ebner F, Günzel D, Richter JF, Hering NA, Schulzke JD, Kühl AA, Keles A, Janczyk P, et al: A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation. Mol Ther. 22:1730–1740. 2014.PubMed/NCBI View Article : Google Scholar

Zoetendal EG, Vaughan EE and De Vos WM: A microbial world within us. Mol Microbiol. 59:1639–1650. 2006.PubMed/NCBI View Article : Google Scholar

Coeuret V, Dubernet S, Bernardeau M, Gueguen M and Vernoux JP: Isolation, characterisation and identification of lactobacilli focusing mainly on cheeses and other dairy products. Lait. 83:269–306. 2003.

Kikuchi Y, Kunitoh-Asari A, Hayakawa K, Imai S, Kasuya K, Abe K, Adachi Y, Fukudome S, Takahashi Y and Hachimura S: Oral administration of Lactobacillus plantarum strain AYA enhances IgA secretion and provides survival protection against influenza virus infection in mice. PLoS One. 9(e86416)2014.PubMed/NCBI View Article : Google Scholar

Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S and Black RE: Efficacy of probiotics in prevention of acute diarrhoea: A meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis. 6:374–382. 2006.PubMed/NCBI View Article : Google Scholar

Wolvers D, Antoine JM, Myllyluoma E, Schrezenmeir J, Szajewska H and Rijkers GT: Guidance for substantiating the evidence for beneficial effects of probiotics: Prevention and management of infections by probiotics. J Nutr. 140:S698–S712. 2010.PubMed/NCBI View Article : Google Scholar

Spath K, Heinl S and Grabherr R: ‘Direct cloning in Lactobacillus plantarum: Electroporation with non-methylated plasmid DNA enhances transformation efficiency and makes shuttle vectors obsolete’. Microb Cell Fact. 11(141)2012.PubMed/NCBI View Article : Google Scholar

Heiss S, Hörmann A, Tauer C, Sonnleitner M, Egger E, Grabherr R and Heinl S: Evaluation of novel inducible promoter/repressor systems for recombinant protein expression in Lactobacillus plantarum. Microb Cell Fact. 15(50)2016.PubMed/NCBI View Article : Google Scholar

Yadav R and Shukla P: An overview of advanced technologies for selection of probiotics and their expediency: A review. Crit Rev Food Sci Nutr. 57:3233–3242. 2017.PubMed/NCBI View Article : Google Scholar

Allain T, Mansour NM, Bahr MMA, Martin R, Florent I, Langella P and Bermúdez-Humarán LG: A new lactobacilli in vivo expression system for the production and delivery of heterologous proteins at mucosal surfaces. FEMS Microbiol Lett. 363(fnw117)2016.PubMed/NCBI View Article : Google Scholar

Rong G, Corrie SR and Clark HA: In vivo biosensing: Progress and perspectives. ACS Sens. 2:327–338. 2017.PubMed/NCBI View Article : Google Scholar

Rowland IR, Rumney CJ, Coutts JT and Lievense LC: Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis. 19:281–285. 1998.PubMed/NCBI View Article : Google Scholar

Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'Riordan M, O'Sullivan GC, Pool-Zobel B, et al: Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr. 85:488–496. 2007.PubMed/NCBI View Article : Google Scholar

Le Leu RK, Hu Y, Brown IL, Woodman RJ and Young GP: Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis. 31:246–251. 2010.PubMed/NCBI View Article : Google Scholar

Bae EA, Han MJ, Song MJ and Kim DH: Purification of Rotavirus infection-inhibitory protein from Bifidobacterium breve K-110. J Microbiol Biotechnol. 12:553–556. 2002.

Patole SK, Rao SC, Keil AD, Nathan EA, Doherty DA and Simmer KN: Benefits of Bifidobacterium breve M-16V Supplementation in preterm neonates-A retrospective cohort study. PLoS One. 11(e0150775)2016.PubMed/NCBI View Article : Google Scholar

Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E, Brigidi P, Matteuzzi D and Campieri M: Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther. 13:1103–1108. 1999.PubMed/NCBI View Article : Google Scholar

Yadav R, Kumar V, Baweja M and Shukla P: Gene editing and genetic engineering approaches for advanced probiotics: A review. Crit Rev Food Sci Nutr. 58:1735–1746. 2018.PubMed/NCBI View Article : Google Scholar

Wei C, Xun AY, Wei XX, Yao J, Wang JY, Shi RY, Yang GH, Li YX, Xu ZL, Lai MG, et al: Bifidobacteria expressing tumstatin protein for antitumor therapy in tumor-bearing mice. Technol Cancer Res Treat. 15:498–508. 2015.PubMed/NCBI View Article : Google Scholar

Xu YF, Zhu LP, Hu B, Fu GF, Zhang HY, Wang JJ and Xu GX: A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy. Cancer Gene Ther. 14:151–157. 2007.PubMed/NCBI View Article : Google Scholar

Zhu LP, Yin Y, Xing J, Li C, Kou L, Hu B, Wu ZW, Wang JJ and Xu GX: Therapeutic efficacy of Bifidobacterium longum-mediated human granulocyte colony-stimulating factor and/or endostatin combined with cyclophosphamide in mouse-transplanted tumors. Cancer Sci. 100:1986–1990. 2009.PubMed/NCBI View Article : Google Scholar

Hu B, Kou L, Li C, Zhu LP, Fan YR, Wu ZW, Wang JJ and Xu GX: Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth. Cancer Gene Ther. 16:655–663. 2009.PubMed/NCBI View Article : Google Scholar

Bolhassani A and Zahedifard F: Therapeutic live vaccines as a potential anticancer strategy. Int J Cancer. 131:1733–1743. 2012.PubMed/NCBI View Article : Google Scholar

Chen T, Zhao X, Ren Y, Wang Y, Tang X, Tian P, Wang H and Xin H: Triptolide modulates tumour-colonisation and anti-tumour effect of attenuated Salmonella encoding DNase I. Appl Microbiol Biotechnol. 103:929–939. 2019.PubMed/NCBI View Article : Google Scholar

Shahabi V, Reyes-Reyes M, Wallecha A, Rivera S, Paterson Y and MacIag P: Development of a Listeria monocytogenes based vaccine against prostate cancer. Cancer Immunol Immunother. 57:1301–1313. 2008.PubMed/NCBI View Article : Google Scholar

Chen Y, Yang D, Li S, Gao Y, Jiang R, Deng L, Frankel FR and Sun B: Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma. Oncogene. 31:2140–2152. 2012.PubMed/NCBI View Article : Google Scholar

Chan CT, Lee JW, Cameron DE, Bashor CJ and Collins JJ: ‘Deadman’ and ‘Passcode’ microbial kill switches for bacterial containment. Nat Chem Biol. 12:82–86. 2016.PubMed/NCBI View Article : Google Scholar

Derrien M, Vaughan EE, Plugge CM and de Vos WM: Akkermansia municiphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 54:1469–1476. 2004.PubMed/NCBI View Article : Google Scholar

Reunanen J, Kainulainen V, Huuskonen L, Ottman N, Belzer C, Huhtinen H, de Vos WM and Satokari R: Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer. Appl Environ Microbiol. 81:3655–3662. 2015.PubMed/NCBI View Article : Google Scholar

Ottman N, Geerlings SY, Aalvink S, de Vos WM and Belzer C: Action and function of Akkermansia muciniphila in microbiome ecology, health and disease. Best Pract Res Clin Gastroenterol. 31:637–642. 2017.PubMed/NCBI View Article : Google Scholar

Thibault R, Blachier F, Darcy-Vrillon B, De Coppet P, Bourreille A and Segain JP: Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: A transport deficiency. Inflamm Bowel Dis. 16:684–695. 2010.PubMed/NCBI View Article : Google Scholar

Puertollano E, Kolida S and Yaqoob P: Biological significance of short-chain fatty acid metabolism by the intestinal microbiome. Curr Opin Clin Nutr Metab Care. 17:139–144. 2014.PubMed/NCBI View Article : Google Scholar

Ottman N, Reunanen J, Meijerink M, Pietilä TE, Kainulainen V, Klievink J, Huuskonen L, Aalvink S, Skurnik M, Boeren S, et al: Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS One. 12(e0173004)2017.PubMed/NCBI View Article : Google Scholar

Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, Chilloux J, Ottman N, Duparc T, Lichtenstein L, et al: A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 23:107–113. 2017.PubMed/NCBI View Article : Google Scholar

Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, et al: Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 384:766–781. 2014.PubMed/NCBI View Article : Google Scholar

Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR and Delzenne NM: Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 50:2374–2383. 2007.PubMed/NCBI View Article : Google Scholar

GBD 2015 Obesity Collaborators. Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, Mokdad AH, Moradi-Lakeh M, et al: Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 377:13–27. 2017.PubMed/NCBI View Article : Google Scholar

Santacruz A, Collado MC, García-Valdés L, Segura MT, Martín-Lagos JA, Anjos T, Martí-Romero M, Lopez RM, Florido J, Campoy C and Sanz Y: Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr. 104:83–92. 2010.PubMed/NCBI View Article : Google Scholar

Karlsson CL, Önnerfält J, Xu J, Molin G, Ahrné S and Thorngren-Jerneck K: The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring). 20:2257–2261. 2012.PubMed/NCBI View Article : Google Scholar

Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, et al: Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 110:9066–9071. 2013.PubMed/NCBI View Article : Google Scholar

Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, Falony G, Raes J, Maiter D, Delzenne NM, et al: Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study. Nat Med. 25:1096–1103. 2019.PubMed/NCBI View Article : Google Scholar

Hu FB, Manson JAE and Willett WC: Types of dietary fat and risk of coronary heart disease: A critical review. J Am Coll Nutr. 20:5–19. 2001.PubMed/NCBI View Article : Google Scholar

Almdal T, Scharling H, Jensen JS and Vestergaard H: The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: A population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med. 164:1422–1426. 2004.PubMed/NCBI View Article : Google Scholar

Maleckas A, Venclauskas L, Wallenius V and Fändriks HL: Metabolic surgery in the treatment of type 2 diabetes mellitus. Oxford Textb Endocrinol Diabetes. 61:257–264. 2011.

Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al: Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 56:1761–1772. 2007.PubMed/NCBI View Article : Google Scholar

Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y and Ji L: Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One. 8(e711108)2013.PubMed/NCBI View Article : Google Scholar

Hansen CH, Krych L, Nielsen DS, Vogensen FK, Hansen LH, Sørensen SJ, Buschard K and Hansen AK: Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia. 55:2285–2294. 2012.PubMed/NCBI View Article : Google Scholar

Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, Prifti E, Vieira-Silva S, Gudmundsdottir V, Pedersen HK, et al: Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 528:262–266. 2015.PubMed/NCBI View Article : Google Scholar

Tedgui A and Mallat Z: Cytokines in atherosclerosis: Pathogenic and regulatory pathways. Physiol Rev. 86:515–581. 2006.PubMed/NCBI View Article : Google Scholar

Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, et al: Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 5(14)2017.PubMed/NCBI View Article : Google Scholar

Jonsson AL and Bäckhed F: Role of gut microbiota in atherosclerosis. Nat Rev Cardiol. 14:79–87. 2017.PubMed/NCBI View Article : Google Scholar

Barrington WT and Lusis AJ: Atherosclerosis: Association between the gut microbiome and atherosclerosis. Nat Rev Cardiol. 14:699–700. 2017.PubMed/NCBI View Article : Google Scholar

Li J, Lin S, Vanhoutte PM, Woo CW and Xu A: Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe^-/- Mice. Circulation. 133:2434–2446. 2016.PubMed/NCBI View Article : Google Scholar

Campion D, Ponzo P, Alessandria C, Saracco GM and Balzola F: The role of microbiota in autism spectrum disorders. Minerva Gastroenterol Dietol. 64:333–350. 2018.PubMed/NCBI View Article : Google Scholar

Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT and Conlon MA: Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl Environ Microbiol. 77:6718–6721. 2011.PubMed/NCBI View Article : Google Scholar

Naito Y, Uchiyama K and Takagi T: A next-generation beneficial microbe: Akkermansia muciniphila. J Clin Biochem Nutr. 63:33–35. 2018.PubMed/NCBI View Article : Google Scholar

Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, et al: Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 359:91–97. 2018.PubMed/NCBI View Article : Google Scholar

Zheng H, Liang H, Wang Y, Miao M, Shi T, Yang F, Liu E, Yuan W, Ji ZS and Li DK: Altered gut microbiota composition associated with eczema in infants. PLoS One. 11(e0166026)2016.PubMed/NCBI View Article : Google Scholar

Wu W, Lv L, Shi D, Ye J, Fang D, Guo F, Li Y, He X and Li L: Protective effect of Akkermansia muciniphila against immune-mediated liver injury in a mouse model. Front Microbiol. 8(1804)2017.PubMed/NCBI View Article : Google Scholar

Png CW, Lindén SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI, McGuckin MA and Florin TH: Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 105:2420–2428. 2010.PubMed/NCBI View Article : Google Scholar

Wang HX, Liu M, Weng SY, Li JJ, Xie C, He HL, Guan W, Yuan YS and Gao J: Immune mechanisms of Concanavalin a model of autoimmune hepatitis. World J Gastroenterol. 18:119–125. 2012.PubMed/NCBI View Article : Google Scholar

Drell T, Larionova A, Voor T, Simm J, Julge K, Heilman K, Tillmann V, Štšepetova J and Sepp E: Differences in gut microbiota between atopic and healthy children. Curr Microbiol. 71:177–183. 2015.PubMed/NCBI View Article : Google Scholar

Lukovac S, Belzer C, Pellis L, Keijser BJ, de Vos WM, Montijn RC and Roeselers G: Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. mBio. 5:e01438–14. 2014.PubMed/NCBI View Article : Google Scholar

van Passel MWJ, Kant R, Zoetendal EG, Plugge CM, Derrien M, Malfatti SA, Chain PS, Woyke T, Palva A, de Vos WM and Smidt H: The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS One. 6(e16876)2011.PubMed/NCBI View Article : Google Scholar

Caputo A, Dubourg G, Croce O, Gupta S, Robert C, Papazian L, Rolain JM and Raoult D: Whole-genome assembly of Akkermansia muciniphila sequenced directly from human stool. Biol Direct. 10(5)2015.PubMed/NCBI View Article : Google Scholar

Guo X, Li S, Zhang J, Wu F, Li X, Wu D, Zhang M, Ou Z, Jie Z, Yan Q, et al: Genome sequencing of 39 Akkermansia muciniphila isolates reveals its population structure, genomic and functional diverisity, and global distribution in mammalian gut microbiotas. BMC Genomics. 18(800)2017.PubMed/NCBI View Article : Google Scholar

Ouwerkerk JP, Aalvink S, Belzer C and De Vos WM: Preparation and preservation of viable Akkermansia muciniphila cells for therapeutic interventions. Benef Microbes. 8:163–169. 2017.PubMed/NCBI View Article : Google Scholar

Ouwerkerk JP, van der Ark KCH, Davids M, Claassens NJ, Finestra TR, de Vos WM and Belzer C: Adaptation of Akkermansia muciniphila to the oxic-anoxic interface of the mucus layer. Appl Environ Microbiol. 82:6983–6993. 2016.PubMed/NCBI View Article : Google Scholar

Vectors DP: Suicide gene therapy of cancer. Mol Ther. 3:S98–S115. 2001.

Baban CK, Cronin M, O'Hanlon D, O'Sullivan GC and Tangney M: Bacteria as vectors for gene therapy of cancer. Bioeng Bugs. 1:385–394. 2010.PubMed/NCBI View Article : Google Scholar

Pedrolli DB, Ribeiro NV, Squizato PN, de Jesus VN and Cozetto DA: Team AQA Unesp at iGEM 2017. Engineering microbial living therapeutics: The synthetic biology toolbox. Trends Biotechnol. 37:100–115. 2019.PubMed/NCBI View Article : Google Scholar

Waller MC, Bober JR, Nair NU and Beisel CL: Toward a genetic tool development pipeline for host-associated bacteria. Curr Opin Microbiol. 38:156–164. 2017.PubMed/NCBI View Article : Google Scholar

Riglar DT and Silver PA: Engineering bacteria for diagnostic and therapeutic applications. Nat Rev Microbiol. 16:214–225. 2018.PubMed/NCBI View Article : Google Scholar

Welker DL, Hughes JE, Steele JL and Broadbent R: High efficiency electrotransformation of Lactobacillus casei. FEMS Microbiol Lett. 362:1–6. 2015.PubMed/NCBI View Article : Google Scholar

Walsh M, Tangney M, O'Neill MJ, Larkin JO, Soden DM, McKenna SL, Darcy R, O'Sullivan GC and O'Driscoll CM: Evaluation of cellular uptake and gene transfer efficiency of pegylated poly-L-lysine compacted DNA: Implications for cancer gene therapy. Mol Pharm. 3:644–653. 2006.PubMed/NCBI View Article : Google Scholar

Ahmad S, Casey G, Sweeney P, Tangney M and O'Sullivan GC: Optimised electroporation mediated DNA vaccination for treatment of prostate cancer. Genet Vaccines Ther. 8(1)2010.PubMed/NCBI View Article : Google Scholar

Kado CI: Historical events that spawned the field of plasmid biology. Microbiol Spectr 2, 2014.

St-Pierre F, Cui L, Priest DG, Endy D, Dodd IB and Shearwin KE: One-step cloning and chromosomal integration of DNA. ACS Synth Biol. 2:537–541. 2013.PubMed/NCBI View Article : Google Scholar

Urnov FD, Rebar EJ, Holmes MC, Zhang HS and Gregory PD: Genome editing with engineered zinc finger nucleases. Nat Rev Genet. 11:636–646. 2010.PubMed/NCBI View Article : Google Scholar

Miller JC, Tan S, Qiao G, Barlow KA, Wang J, Xia DF, Meng X, Paschon DE, Leung E, Hinkley SJ, et al: A TALE nuclease architecture for efficient genome editing. Nat Biotechnol. 29:143–148. 2011.PubMed/NCBI View Article : Google Scholar

Wang HH, Isaacs FJ, Carr PA, Sun ZZ, Xu G, Forest CR and Church GM: Programming cells by multiplex genome engineering and accelerated evolution. Nature. 460:894–898. 2009.PubMed/NCBI View Article : Google Scholar

Kuipers OP, Beerthuyzen MM, de Ruyter PG, Luesink EJ and de Vos WM: Autoregulation of nisin biosynthesis in lactococcus lactis by signal transduction. J Biol Chem. 270:27299–27304. 1995.PubMed/NCBI View Article : Google Scholar

Van der Meer JR, Polman J, Beerthuyzen MM, Siezen RJ, Kuipers OP and De Vos WM: Characterization of the Lactococcus lactis nisin A operon genes nisP, encoding a subtilisin-like serine protease involved in precursor processing, and nisR, encoding a regulatory protein involved in nisin biosynthesis. J Bacteriol. 175:2578–2588. 1993.PubMed/NCBI View Article : Google Scholar

Engelke G, Gutowski-Eckel Z, Kiesau P, Siegers K, Hammelmann M and Entian KD: Regulation of nisin biosynthesis and immunity in Lactococcus lactis 6F3. Appl Environ Microbiol. 60:814–825. 1994.PubMed/NCBI View Article : Google Scholar

Kleerebezem M, Bongers R, Rutten G, Vos WMD and Kuipers OP: Autoregulation of subtilin biosynthesis in Bacillus subtilis: The role of the spa-box in subtilin-responsive promoters. Peptides. 25:1415–1424. 2004.PubMed/NCBI View Article : Google Scholar

Mohseni AH, Razavilar V, Keyvani H, Razavi MR and Khavari-Nejad RA: Efficient production and optimization of E7 oncoprotein from Iranian human papillomavirus type 16 in Lactococcus lactis using nisin-controlled gene expression (NICE) system. Microb Pathog. 110:554–560. 2017.PubMed/NCBI View Article : Google Scholar

Van Hoang V, Ochi T, Kurata K, Arita Y, Ogasahara Y and Enomoto K: Nisin-induced expression of recombinant T cell epitopes of major Japanese cedar pollen allergens in Lactococcus lactis. Appl Microbiol Biotechnol. 102:261–268. 2018.PubMed/NCBI View Article : Google Scholar

Kaiser AD: A genetic study of the temperate coliphage λ. Virology. 1:424–443. 1955.PubMed/NCBI View Article : Google Scholar

Carter DM and Radding CM: The role of exonuclease and beta protein of phage lambda in genetic recombination. II. Substrate specificity and the mode of action of lambda exonuclease. J Biol Chem. 246:2502–2512. 1971.PubMed/NCBI

Murphy KC: Lambda Gam protein inhibits the helicase and chi-stimulated recombination activities of Escherichia coli RecBCD enzyme. J Bacteriol. 173:5808–5821. 1991.PubMed/NCBI View Article : Google Scholar

Karu AE, Sakaki Y, Echols H and Linn S: The gamma protein specified by bacteriophage gamma. Structure and inhibitory activity for the recBC enzyme of Escherichia coli. J Biol Chem. 250:7377–7387. 1975.PubMed/NCBI

Murphy KC: λ recombination and recombineering. EcoSal Plus 7, 2016.

Juhas M and Ajioka JW: Lambda Red recombinase-mediated integration of the high molecular weight DNA into the Escherichia coli chromosome. Microb Cell Fact. 15(172)2016.PubMed/NCBI View Article : Google Scholar

Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J and Charpentier E: CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature. 471:602–607. 2011.PubMed/NCBI View Article : Google Scholar

Bolotin A, Quinquis B, Sorokin A and Dusko Ehrlich S: Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology (Reading). 151:2551–2561. 2005.PubMed/NCBI View Article : Google Scholar

Deveau H, Barrangou R, Garneau JE, Labonté J, Fremaux C, Boyaval P, Romero DA, Horvath P and Moineau S: Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol. 190:1390–1400. 2008.PubMed/NCBI View Article : Google Scholar

Tong Y, Charusanti P, Zhang L, Weber T and Lee SY: CRISPR-Cas9 based engineering of actinomycetal genomes. ACS Synth Biol. 4:1020–1029. 2015.PubMed/NCBI View Article : Google Scholar

Garneau JE, Dupuis MÈ, Villion M, Romero DA, Barrangou R, Boyaval P, Fremaux C, Horvath P, Magadán AH and Moineau S: The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature. 468:67–71. 2010.PubMed/NCBI View Article : Google Scholar

Jiang W, Bikard D, Cox D, Zhang F and Marraffini LA: RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol. 31:233–239. 2013.PubMed/NCBI View Article : Google Scholar

Oh JH and Van Pijkeren JP: CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri. Nucleic Acids Res. 42(e131)2014.PubMed/NCBI View Article : Google Scholar

van der Els S, James JK, Kleerebezem M and Bron PA: Versatile Cas9-driven subpopulation selection toolbox for Lactococcus lactis. Appl Environ Microbiol. 84:e02752–17. 2018.PubMed/NCBI View Article : Google Scholar

Manghwar H, Lindsey K, Zhang X and Jin S: CRISPR/Cas system: Recent advances and future prospects for genome editing. Trends Plant Sci. 24:1102–1125. 2019.PubMed/NCBI View Article : Google Scholar

Gauttam R, Seibold GM, Mueller P, Weil T, Weiß T, Handrick R and Eikmanns BJ: A simple dual-inducible CRISPR interference system for multiple gene targeting in Corynebacterium glutamicum. Plasmid. 103:25–35. 2019.PubMed/NCBI View Article : Google Scholar

Crawley AB, Henriksen JR and Barrangou R: CRISPRdisco: An automated pipeline for the discovery and analysis of CRISPR-Cas systems. CRISPR J. 1:171–181. 2018.PubMed/NCBI View Article : Google Scholar

Takei S, Omoto C, Kitagawa K, Morishita N, Katayama T, Shigemura K, Fujisawa M, Kawabata M, Hotta H and Shirakawa T: Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice. Vaccine. 32:3066–3074. 2014.PubMed/NCBI View Article : Google Scholar

Pathmakanthan S, Meance S and Edwards CA: Probiotics: A review of human studies to date and methodological approaches. Microb Ecol Health Dis. 12:10–30. 2000.

Lawenius L, Scheffler JM, Gustafsson KL, Henning P, Nilsson KH, Colldén H, Islander U, Plovier H, Cani PD, de Vos WM, et al: Pasteurized Akkermansia muciniphila protects from fat mass gain but not from bone loss. Am J Physiol Endocrinol Metab. 318:E480–E491. 2020.PubMed/NCBI View Article : Google Scholar